▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3696 by analyst upside · 2026-11-12
MOH
Molina Healthcare, Inc.
Healthcare · Market Cap $11B · P/E 0x
ANALYST PRICE TARGET
+4.9%
implied upside to consensus target
Current Price $209.25
Consensus Target $219.53
Bull Target $266.0
Bear Target $163.0
Analysts Covering 17
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
3
Hold
13
Sell
1
52-Week Low $121.06
52-Week High $244.89
YTD Return +17.3%
FUNDAMENTALS
Market Cap $11B
P/E Ratio (TTM) N/A
Forward P/E 21.9x
EPS (TTM) $-0.68
PEG Ratio 1.12
Dividend Yield N/A
Revenue (TTM) $42.1B
Profit Margin -0.1%
52-WEEK RANGE
52-Week Low $121.06
52-Week High $244.89
Current Price $209.25
Bear Target $163.0
Bull Target $266.0
● Now $209.25 ● Target $219.53
TRADING DATA
Avg Volume 764K
YTD Return +17.3%
Analyst Count 17
Consensus Hold
Upside to Target +4.9%
Last Updated 2026-11-12

ANALYST SUMMARY

Molina Healthcare, Inc. (MOH) is currently trading at $209.25 with a Wall Street consensus price target of $219.53, implying potential upside of 4.9% over the next 12 months. 17 analysts currently cover MOH, with a consensus rating of Hold - 18% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $266.0, while the most cautious has a target of $163.0.

MOH operates in the Healthcare sector with a market capitalisation of $11B. The stock is up 17.3% year-to-date and is currently trading near the upper end of its 52-week range of $121.06 – $244.89.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

FMS +0.1%
Fresenius Medical Care AG
$12B · P/E 13.1x · Hold
UHS -0.8%
Universal Health Services, Inc.
$11B · P/E 8.2x · Hold
GMED +23.9%
Globus Medical, Inc.
$10B · P/E 18.5x · Buy
SNN +6.9%
Smith & Nephew plc
$13B · P/E 21.0x · Hold
PODD +19.0%
Insulet Corporation
$10B · P/E 24.2x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for MOH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan - Reiterated
Neutral → Neutral 2026-10-27 43% win rate (7 calls)
UBS - Reiterated
Neutral → Neutral 2026-10-23 33% win rate (6 calls)
Morgan Stanley - Reiterated
Equal-Weight → Equal-Weight 2026-10-23 Building track record
RBC Capital - Reiterated
Sector Perform → Sector Perform 2026-10-23 Building track record
Barclays - Reiterated
Underweight → Underweight 2026-10-23 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-07-28 Building track record
Truist Securities - Reiterated
Hold → Hold 2026-07-24 Building track record
RBC Capital - Reiterated
Sector Perform → Sector Perform 2026-07-24 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
44
out of 100
Coverage depth
22/30
Consensus clarity
20/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →